Mankind Pharma has received a certificate regarding the Depositories and Participants Regulations for the quarter ended September 30, 2025. The certificate, received from KFin Technologies Limited, confirms compliance with regulatory requirements related to dematerialization and rematerialization of shares. This announcement indicates Mankind Pharma’s adherence to regulatory standards.
Regulatory Compliance Confirmation
Mankind Pharma has secured a certificate confirming adherence to the Depositories and Participants Regulations for Q2 2025. This certificate was issued by KFin Technologies Limited, the Registrar and Share Transfer Agent for Mankind Pharma.
Details of the Certificate
The certificate confirms that, for the period between July 01, 2025, and September 30, 2025, KFin Technologies Limited did not receive any requests for dematerialization or rematerialization of shares of Mankind Pharma Limited. This is in accordance with the specified regulations.
Source: BSE
